Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Haemonetics Corporation (NYSE:HAE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 21Price hit new 52-week high ($37.50)
Location
400 Wood Road
Braintree, MA 02184
Phone: (781) 848-7100
Fax: (781) 848-5106
Email: investor@haemonetics.com
Employees (last reported count): 1,357
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 77%
·Over the last 6 months:
 · 6 insider sells; 540.0K shares
  (2.6% of insider shares)
·Institutional: 93% (404% of float)
(223 institutions)
·Net Inst. Selling: 91.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Haemonetics Corporation is engaged in the manufacture of automated systems for the collection, processing and surgical salvage of blood. The Company manages its business on the basis of one operating segment- the design, manufacture and marketing of automated blood processing systems. Haemonetics' products address five important therapeutic markets for blood and blood components: surgical blood salvage, automated plasma collection, automated platelet collection, automated red cell collection and cell processing. Haemonetics' blood processing systems consist of proprietary disposable sets driven by specialized equipment.
More from Market Guide: Expanded Business Description

Financial Summary
HAE is engaged in the design, manufacture, and worldwide marketing of automated systems for the collection, processing and surgical salvage of blood. For the three months ended 6/30/01, revenues rose 8% to $75.8 million. Net income before acct. chg. rose 23% to $7.6 million. Revenues reflect increased red cell, plasma, and surgical product line sales. Net income also benefited from increased gross profit margins and the adoption of the FAS 142 accounting change.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2001 Pay

Stuart Burgess, 72
Chairman
--  
James Peterson, 58
Pres, CEO, Vice Chairman
$916K
Ronald Ryan
CFO, Sr. VP
358K
Thomas Headley
Exec. VP - Worldwide R&D
1.3M
Timothy Surgenor
Exec. VP - Bus. Dev., Advanced R&D, Worldwide Solutions Bus., and Quality Assurance
319K
Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:HAEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 18-Oct-2000
$21.25 
Recent Price$35.86 
52-Week High
on 21-Aug-2001
$37.50 
Beta0.05 
Daily Volume (3-month avg)69.1K
Daily Volume (10-day avg)65.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+42.0%
52-Week Change
relative to S&P500
+90.5%
Share-Related Items
Market Capitalization$937.0M
Shares Outstanding26.1M
Float6.00M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 11-Jan-1993
Per-Share Data
Book Value (mrq)$9.00 
Earnings (ttm)$0.30 
Earnings (mrq)$0.28 
Sales (ttm)$11.45 
Cash (mrq)$3.52 
Valuation Ratios
Price/Book (mrq)3.98 
Price/Earnings (ttm)120.74 
Price/Sales (ttm)3.13 
Income Statements
Sales (ttm)$299.4M
EBITDA (ttm)$39.4M
Income available to common (ttm)$8.65M
Profitability
Profit Margin (ttm)2.9%
Operating Margin (ttm)5.0%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)2.52%
Return on Equity (ttm)4.12%
Financial Strength
Current Ratio (mrq)2.88 
Debt/Equity (mrq)0.32 
Total Cash (mrq)$92.0M
Short Interest
As of 8-Aug-2001
Shares Short197.0K
Percent of Float3.3%
Shares Short
(Prior Month)
30.0K
Short Ratio2.85 
Daily Volume69.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.